Verdejo, Miguel Ángel https://orcid.org/0000-0001-7870-0515
Perissinotti, Andrés
Malano-Barletta, Daniela
Pitart, Cristina
Cuervo, Guillermo
Hernández-Meneses, Marta
Bodro, Marta
Herrera, Sabina
García-Vidal, Carolina
Puerta-Alcalde, Pedro
Martínez, José Antonio
del Río, Ana
Espasa, Mateu
Fuster, David
Morata, Laura
Soriano, Alex
Funding for this research was provided by:
Instituto de Salud Carlos III (Juan Rodés Research Grant (JR23/00025))
Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union (PI19/01116, PI19/01116)
Article History
Received: 24 February 2025
Accepted: 29 April 2025
First Online: 7 May 2025
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board (IRB), “Comité de Ética de la Investigación con Medicamentos (CEIM) del Hospital Clínic de Barcelona” (approval reference HCB-2023–0507). Due to the retrospective and anonymized observational design of the study, the need for informed consent to participate was waived by the IRB (CEIM).
: Not applicable.
: The authors declare no competing interests.